You are receiving this email because you signed up for the monthly ASI Newsletter. 

If you no longer wish to receive these emails you can unsubscribe here.

August 2025 - Antivenom Crisis 

Snakebite antivenom was first produced in South Africa in 1901 and in small quantities. For the next 30-odd years, antivenom was largely imported from the Pasteur Institute in France. During that period, a 10 ml vial of cobra or mamba antivenom could be purchased from Mr. F.W. Fitzsimons, Director of the Port Elizabeth Museum.

In 1928, the South African Institute of Medical Research (SAIMR) started antivenom production. They experimented with a variety of domestic animals for serum production but ultimately settled on horses, largely because of the large volume of blood that can be tapped during a session. Horses are made hyperimmune to snake venom by injecting them with small quantities of venom at a time, gradually increasing the dosages as the horse builds up resistance to the venom. Once the horse is immune, a process that takes about nine months, blood is taken from it and the serum removed from the blood cells and purified.
 

Mr Frederick William FitzSimons director of the Port Elizabeth/Bayworld Museum from 1906–1936. He started the first snake park in Africa in 1919 and was the only supplier of antivenom.

Image - https://www.bayworld.co.za/pemherp

There were various antivenoms produced over the years, but in 1971, SAIMR produced a polyvalent antivenom which, in its preparation, used venom from the Snouted Cobra, Forest Cobra, Mozambique Spitting Cobra and the Black-necked Spitting Cobra. This was changed at a later stage, and the venom from the Green Mamba, Black Mamba, Jameson’s Mamba, Cape Cobra, Snouted Cobra, Forest Cobra, Mozambique Spitting Cobra, Rinkhals, Puff Adder and Gaboon Adder was used in the production of the current polyvalent antivenom.  A monovalent antivenom, which is effective against the venom of the Boomslang, was produced in 1940

The SAIMR was rebranded as the National Health Laboratories, and venom production was done by the South African Vaccine Producers, a government department.

In cases of serious snakebite envenomation, it is recommended that victims bitten by highly venomous snakes with cytotoxic venom receive 6 vials of SAVP polyvalent antivenom, and those bitten by a snake with neurotoxic venom should initially be treated with 12 vials. More antivenom may be required at a later stage.
Boomslang victims should ideally be treated with two vials of monovalent Boomslang antivenom. The antivenom is given intravenously via a saline drip and usually over half an hour.

As Boomslang bites are not common, Boomslang monovalent antivenom is still available from SAVP stockpiles. 

Both SAVP antivenoms are supplied in liquid form in a 10 ml glass vial and must always be refrigerated (not frozen) below 10 degrees centigrade. The shelf life of these antivenoms is three years after which it may not be legally used on humans. Provided the expired antivenom remains clear and not cloudy or milky, it can be used by vets on pets with success. Most snakebite victims who are hospitalised after a snakebite are not treated with antivenom, as not all bites are severe. Doctors will closely monitor the patient’s symptoms and administer antivenom if required. Up to 40% of snakebite victims that are treated with SAVP antivenom have a severe allergic reaction, and for this reason, antivenom is only administered by a medical professional in a hospital environment.

There have been many instances in the past when the SAVP ran short of antivenom, and orders were often delayed for a few weeks. However, since COVID they have experienced severe production problems and for the past year or so SAVP have not produced any antivenom. They no longer have stock of SAVP polyvalent antivenom and in their last correspondence mentioned that they are busy upgrading their facilities and hope to be back in production by April 2025. This never happened and at this stage it is doubtful that they will ever produce antivenom again.

SAVP Polyvalent antivenom is a very effective antivenom against many highly venomous African snakes but unfortunately is very difficult to source currently. 

There are several antivenom producers in India and South America that produce antivenoms which are sold in Africa. Most of these antivenoms perform rather poorly when it comes to neutralising the venom of southern African snakes and none of them have been subjected to clinical trials.

For these products, which are not registered with the South African Health Products Regulatory Authority (SAPHRA) they must be imported under section 21 of SAHPRA, and this requires a great deal of paperwork. Only one product, PANAF Polyvalent, is currently in the process of being registered with SAPHRA in South Africa for human use.

PANAF Polyvalent has been produced since 2015 and is currently the only World Health Organization (WHO) approved snake antivenom for use in Africa and has an internationally recognised GMP code (Good Manufacturing Practice). It is sold in powder form with sterile water, can be stored at room temperature up to 30 degrees centigrade and has a shelf life of four years. It covers 24 African species including, the Puff Adder, Gaboon Adder, our cobras and mambas and provides cross-neutralisation for the Cape Cobra and Rinkhals, although their venoms are not, as yet, added to the mix.

The future of Africa - Panaf Polyvalent antivenom. 

PANAF has already been registered in Namibia and Botswana and is in the process of being fully registered in South Africa with SAPHRA. This product is already being used in our private and state hospitals and by veterinarians.

The cost of PANAF Polyvalent antivenom is like that of SAVP polyvalent antivenom, around R2,000.00 per vial. The recommended initial dosages are somewhat higher – 10 vials for Puff Adder bites, 10-15 vials for Black and Green Mamba bites, 10 vials for Mozambique Spitting Cobra bites and 10-20 vials for Cape Cobra bites. One major plus side is that we have not recorded allergic reactions to this product so far. At this stage, PANAF does not produce antivenom for Boomslang bites.

PANAF is already in use in Zimbabwe, Angola, Mozambique, Zambia, Namibia, Botswana and various other sub-Saharan countries.

Our brand-new ASI Snake Booklets are here!
A big leap forward in local snake education.

We’ve released the first 95 booklets, each dedicated to a specific city or town in South Africa – and they’re all available as FREE PDF downloads from our website.

Inside each booklet, you’ll find:
• The snakes found in your area
• How to identify them
• Snakebite first aid
• Nearby hospitals
• Contact details for local snake removers

Start learning about the snakes in your town today!

Download the PDFs here: https://bit.ly/46MEbgz

FIND US ON SOCIAL MEDIA 
 

Johan Marais
African Snakebite Institute | +27 82 494 2039
E-mail johan@asiorg.co.za 
Find out more at www.africansnakebiteinstitute.com

Johan Marais is the author of various books on reptiles including the best-seller - A Complete Guide to Snakes of Southern Africa. He is a popular public speaker and CEO of the African Snakebite Institute. The African Snakebite Institute (ASI) offers a variety of courses including Snake Awareness, Scorpion Awareness and Venomous Snake Handling. ASI is accredited by the International Society of Zoological Sciences (ISZS) and is a Travel Doctor-approved service provider. The courses are also accredited by the Health Professions Council of South Africa (HPCSA). ASI is the largest provider of quality snake handling and safety equipment in Africa!

Copyright © 2025 African Snakebite Institute, All rights reserved.

Our mailing address is:
admin@asiorg.co.za
unsubscribe from this list